NO301480B1 - Fremgangsmåte for enzymatisk fremstilling av basisk fibroblastfaktor - Google Patents

Fremgangsmåte for enzymatisk fremstilling av basisk fibroblastfaktor Download PDF

Info

Publication number
NO301480B1
NO301480B1 NO921236A NO921236A NO301480B1 NO 301480 B1 NO301480 B1 NO 301480B1 NO 921236 A NO921236 A NO 921236A NO 921236 A NO921236 A NO 921236A NO 301480 B1 NO301480 B1 NO 301480B1
Authority
NO
Norway
Prior art keywords
bfgf
heparin
column
thr
pepsin
Prior art date
Application number
NO921236A
Other languages
English (en)
Norwegian (no)
Other versions
NO921236L (no
NO921236D0 (no
Inventor
Pierre Monsan
Francois Paul
Didier Betbeder
Paolo Sarmientos
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO921236L publication Critical patent/NO921236L/no
Publication of NO921236D0 publication Critical patent/NO921236D0/no
Publication of NO301480B1 publication Critical patent/NO301480B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO921236A 1990-08-02 1992-03-30 Fremgangsmåte for enzymatisk fremstilling av basisk fibroblastfaktor NO301480B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909017008A GB9017008D0 (en) 1990-08-02 1990-08-02 Process for the enzymatic preparation of basic fibroblast growth factor
PCT/EP1991/001428 WO1992002539A1 (en) 1990-08-02 1991-07-30 Process for the enzymatic preparation of basic fibroblast growth factor

Publications (3)

Publication Number Publication Date
NO921236L NO921236L (no) 1992-03-30
NO921236D0 NO921236D0 (no) 1992-03-30
NO301480B1 true NO301480B1 (no) 1997-11-03

Family

ID=10680087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921236A NO301480B1 (no) 1990-08-02 1992-03-30 Fremgangsmåte for enzymatisk fremstilling av basisk fibroblastfaktor

Country Status (27)

Country Link
US (1) US5348863A (cs)
EP (1) EP0495049B1 (cs)
JP (1) JPH05501655A (cs)
KR (1) KR100191697B1 (cs)
CN (1) CN1033810C (cs)
AT (1) ATE152122T1 (cs)
AU (1) AU643822B2 (cs)
CA (1) CA2066174A1 (cs)
CZ (1) CZ286237B6 (cs)
DE (1) DE69125810T2 (cs)
DK (1) DK0495049T3 (cs)
ES (1) ES2103822T3 (cs)
FI (1) FI921428A0 (cs)
GB (1) GB9017008D0 (cs)
GR (1) GR3024111T3 (cs)
HU (1) HU212671B (cs)
IE (1) IE912729A1 (cs)
IL (1) IL98988A (cs)
MY (1) MY107334A (cs)
NO (1) NO301480B1 (cs)
NZ (1) NZ239204A (cs)
PH (1) PH31240A (cs)
PT (1) PT98544B (cs)
RU (1) RU2093519C1 (cs)
WO (1) WO1992002539A1 (cs)
YU (1) YU48309B (cs)
ZA (1) ZA916026B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659723B2 (en) * 1992-02-14 1995-05-25 Kaken Pharmaceutical Co., Ltd. Remedy for airway diseases
CZ289439B6 (cs) * 1994-04-21 2002-01-16 Novo Nordisk A/S Farmaceutický prostředek pro prevenci nebo léčbu sepse
US5939390A (en) * 1995-03-09 1999-08-17 Novo Nordisk A/S Pharmaceutical composition
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
RU2187118C2 (ru) * 2000-07-13 2002-08-10 Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова Способ диагностики возможности рецидивов церебральных рацемозных артериовенозных мальформаций
IL141647A0 (en) 2001-02-26 2002-03-10 Yeda Res & Dev Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
BRPI0406647A (pt) 2003-01-06 2005-12-06 Angiochem Inc Método para transportar um composto através da barreira sanguìnea do cérebro
UA83816C2 (ru) 2003-01-14 2008-08-26 Тева Фармасьютикал Индастриз, Лтд ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ СОДЕРЖИТ ПЕПТИД И ЗАМЕЩЕННЫЙ β-ЦИКЛОДЕКСТРИН, ДЛЯ ЛЕЧЕНИЯ СИСТЕМНОЙ КРАСНОЙ ВОЛЧАНКИ
JP5064212B2 (ja) 2004-05-05 2012-10-31 ヴァロリザーシヨン−ルシェルシュ，ソシエテ・アン・コマンディット インターロイキン−１受容体アンタゴニスト、組成物、及び治療方法
US8618054B2 (en) 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
WO2007004060A2 (en) 2005-05-05 2007-01-11 Valorisation Hsj, Societe En Commandite Cytokine receptor modulators and uses thereof
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2008144919A1 (en) 2007-05-29 2008-12-04 Angiochem, Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CN102026667B (zh) 2008-04-18 2014-06-25 安吉奥开米公司 紫杉醇、紫杉醇类似物或紫杉醇结合物的药物组合物及相关制备方法和用途
MX2011004019A (es) 2008-10-15 2011-06-24 Angiochem Inc Conjugados de etoposido y doxorubicina para entrega de farmacos.
JP2012505637A (ja) 2008-10-15 2012-03-08 アンジオケム，インコーポレーテッド Ｇｌｐ−１アゴニストのコンジュゲート及びその使用
MX2011005963A (es) 2008-12-05 2011-09-01 Angiochem Inc Conjugados de neurotensina o analogos de neurotensina y sus usos.
EP2373789A4 (en) 2008-12-17 2012-08-29 Angiochem Inc MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
US9173891B2 (en) 2009-04-20 2015-11-03 Angiochem, Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
JP5932642B2 (ja) 2009-07-02 2016-06-08 アンジオケム インコーポレーテッド 多量体ペプチドコンジュゲートおよびその使用
WO2012000118A1 (en) 2010-07-02 2012-01-05 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
BR112015028710A2 (pt) * 2013-05-16 2017-09-19 Agency Science Tech & Res Sulfato de heparan hs8 isolado ou substancialmente purificado, composição farmacêutica ou medicamento, implante biocompatível ou prótese, método de formação de um implante ou prótese biocompatível, método de cultivo de células-tronco, método de enriquecimento para unidades formadoras de colônias, meio de cultura, kit de peças, produtos e método para aumentar a estabilidade de um fator de crescimento
US10493012B2 (en) 2014-11-19 2019-12-03 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
SG11201704085QA (en) 2014-11-19 2017-06-29 Agency Science Tech & Res Heparan sulphates for use in repair and/or regeneration of skin
JP6823055B2 (ja) 2015-06-15 2021-01-27 アンジオケム インコーポレーテッド 軟髄膜癌腫症の治療方法
CN105294851B (zh) * 2015-12-07 2019-02-12 中国科学院长春应用化学研究所 与几丁质特异结合的碱性成纤维细胞生长因子及其编码基因、制备方法与应用
CN114965839A (zh) * 2022-05-11 2022-08-30 朗肽生物制药股份有限公司 人碱性成纤维细胞生长因子的肽图分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
DE3811921A1 (de) * 1988-04-09 1989-10-19 Hoechst Ag Verfahren zur herstellung von proteinen, die n-terminal mit prolin beginnen
US5136025A (en) * 1990-04-04 1992-08-04 California Biotechnology Inc. Method to purify basic fibroblast growth factor

Also Published As

Publication number Publication date
YU48309B (sh) 1998-05-15
US5348863A (en) 1994-09-20
CS236291A3 (en) 1992-02-19
PT98544B (pt) 1999-01-29
NO921236L (no) 1992-03-30
IE912729A1 (en) 1992-02-12
JPH05501655A (ja) 1993-04-02
ZA916026B (en) 1992-04-29
NZ239204A (en) 1993-11-25
DK0495049T3 (da) 1997-08-25
DE69125810D1 (de) 1997-05-28
FI921428A7 (fi) 1992-04-01
EP0495049B1 (en) 1997-04-23
PT98544A (pt) 1992-06-30
CN1058597A (zh) 1992-02-12
PH31240A (en) 1998-06-18
AU643822B2 (en) 1993-11-25
CA2066174A1 (en) 1992-02-03
KR100191697B1 (ko) 1999-06-15
GR3024111T3 (en) 1997-10-31
KR920702371A (ko) 1992-09-03
HUT64564A (en) 1994-01-28
WO1992002539A1 (en) 1992-02-20
EP0495049A1 (en) 1992-07-22
FI921428L (fi) 1992-04-01
CZ286237B6 (cs) 2000-02-16
IL98988A (en) 1997-02-18
HU9201101D0 (en) 1992-08-28
FI921428A0 (fi) 1992-04-01
YU131991A (sh) 1994-05-10
ES2103822T3 (es) 1997-10-01
IL98988A0 (en) 1992-07-15
RU2093519C1 (ru) 1997-10-20
MY107334A (en) 1995-11-30
AU8304491A (en) 1992-03-02
NO921236D0 (no) 1992-03-30
GB9017008D0 (en) 1990-09-19
DE69125810T2 (de) 1997-08-07
ATE152122T1 (de) 1997-05-15
CN1033810C (zh) 1997-01-15
HU212671B (en) 1996-09-30

Similar Documents

Publication Publication Date Title
NO301480B1 (no) Fremgangsmåte for enzymatisk fremstilling av basisk fibroblastfaktor
JP3205578B2 (ja) キメラ繊維芽細胞成長因子
Abad et al. Properties of a chloroplast enzyme that cleaves the chlorophyll a/b binding protein precursor: optimization of an organelle-free reaction
Kim et al. Construction of chimeric human epidermal growth factor containing short collagen-binding domain moieties for use as a wound tissue healing agent
JP3011274B2 (ja) 組み換え技術により産生した、３−デス−ヒドロキシ−シスタチンｃポリペプチドまたはその修飾物
EP0587541B1 (en) Process to purify the big-endothelin protein
DE69324547T2 (de) Protease, die menschlichen Hepatozytwachtumsfaktor umsetzt, und dafür kodierendes Gen
US6077694A (en) Method for over-expression and rapid purification of biosynthetic proteins
US5656458A (en) Expression and processing of amino terminus acetylated FGF's in yeast
Gonnelli et al. Purification and characterization of two leaf polypeptide inhibitors of leaf protease from alfalfa (Medicago sativa)
CA2369973C (en) Preparation of pancreatic procarboxypeptidase b, isoforms and muteins thereof and their use
WO1991015589A1 (en) Improved process of purifying recombinant proteins and compounds useful in such process
JPH06327489A (ja) 遺伝子操作による生物活性β−ＮＧＦの生産方法
JP2877253B2 (ja) 融合タンパク質の選択的切断方法
CN101736008B (zh) 一种制备基因工程N-乙酰化胸腺素α1的方法
Betbeder et al. Production of homogeneous basic fibroblast growth factor by specific enzymatic hydrolysis of larger microheterogeneous molecular forms
CN116334051A (zh) 一种对核酸提取裂解液中异硫氰酸胍耐受时间延长的蛋白酶k突变体及其应用
KR20210148288A (ko) 생체내 리폴딩된 항체 단편의 클로닝 및 발현
MXPA01009979A (en) Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use
Banaś-Gruszka et al. Amino acid composition ana N-terminal residues of goose, duck and hen prothrombin
Fiol Cloning, production and site-directed mutagenesis of bovine pancreatic ribonuclease A in Escherichia coli
Chen Biochemical and molecular biological studies on the mammalian multiubiquitinating enzyme E2 (25K)
JPH1052278A (ja) 機能性ポリペプチドの製造方法
JPH02222690A (ja) ヒト５―リポキシゲナーゼの酵母による製造法
JPH1052279A (ja) 機能性ポリペプチドの製造方法

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2001